Literature DB >> 9510849

Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders.

C G Costa1, L Dorland, U Holwerda, I T de Almeida, B T Poll-The, C Jakobs, M Duran.   

Abstract

We present a new derivatization procedure for the simultaneous gas chromatographic-mass spectrometric analysis of free fatty acids and 3-hydroxyfatty acids in plasma. Derivatization of target compounds involved trifluoroacetylation of hydroxyl groups and tert-butyldimethylsilylation of the carboxyl groups. This new derivatization procedure had the advantage of allowing the complete baseline separation of free fatty acids and 3-hydroxyfatty acids while the superior gas chromatographic and mass spectrometric properties of tert-butyldimethylsilyl derivatives remained unchanged, permitting a sensitive analysis of the target compounds. Thirty-nine plasma samples from control subjects and patients with known defects of mitochondrial fatty acid beta-oxidation were analyzed. A characteristic increase of long-chain 3-hydroxyfatty acids was observed for all of the long-chain 3-hydroxyacyl-CoA dehydrogenase-deficient and mitochondrial trifunctional protein-deficient plasma samples. For medium-chain acyl-CoA dehydrogenase deficiency and very-long-chain acyl-CoA dehydrogenase deficiency, decenoic and tetradecenoic acids, respectively, were the main abnormal fatty acids, whereas the multiple acyl-CoA dehydrogenase-deficient patients showed variable increases of these unusual intermediates. The results showed that this selective and sensitive method is a powerful tool in the diagnosis and monitoring of mitochondrial fatty acid beta-oxidation disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510849

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  23 in total

1.  Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.

Authors:  Kashan Ahmed; Sorin Tunaru; Claus-Dieter Langhans; Julien Hanson; Christoph W Michalski; Stefan Kölker; Patricia M Jones; Jürgen G Okun; Stefan Offermanns
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

2.  Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.

Authors:  J J Shen; D Matern; D S Millington; S Hillman; M D Feezor; M J Bennett; M Qumsiyeh; S G Kahler; Y T Chen; J L Van Hove
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

3.  Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.

Authors:  Melanie B Gillingham; Richard G Weleber; Martha Neuringer; William E Connor; Monte Mills; Sandy van Calcar; James Ver Hoeve; Jon Wolff; Cary O Harding
Journal:  Mol Genet Metab       Date:  2005-07-22       Impact factor: 4.797

4.  Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects.

Authors:  P Divry; C Vianey-Saban; M Mathieu
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

5.  Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition.

Authors:  Louise B Thingholm; Malte C Rühlemann; Manja Koch; Brie Fuqua; Guido Laucke; Ruwen Boehm; Corinna Bang; Eric A Franzosa; Matthias Hübenthal; Ali Rahnavard; Fabian Frost; Jason Lloyd-Price; Melanie Schirmer; Aldons J Lusis; Chris D Vulpe; Markus M Lerch; Georg Homuth; Tim Kacprowski; Carsten O Schmidt; Ute Nöthlings; Tom H Karlsen; Wolfgang Lieb; Matthias Laudes; Andre Franke; Curtis Huttenhower
Journal:  Cell Host Microbe       Date:  2019-08-06       Impact factor: 21.023

6.  Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

Authors:  Rohit Sharma; Bryn Reinstadler; Kristin Engelstad; Owen S Skinner; Erin Stackowitz; Ronald G Haller; Clary B Clish; Kerry Pierce; Melissa A Walker; Robert Fryer; Devin Oglesbee; Xiangling Mao; Dikoma C Shungu; Ashok Khatri; Michio Hirano; Darryl C De Vivo; Vamsi K Mootha
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

7.  Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency.

Authors:  J L Van Hove; S G Kahler; M D Feezor; J P Ramakrishna; P Hart; W R Treem; J J Shen; D Matern; D S Millington
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

8.  Long-chain 3-hydroxy fatty acids accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria.

Authors:  Anelise M Tonin; Alexandre U Amaral; Estela N B Busanello; Mateus Grings; Roger F Castilho; Moacir Wajner
Journal:  J Bioenerg Biomembr       Date:  2012-10-13       Impact factor: 2.945

9.  Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor.

Authors:  Masakatsu Suzuki; Sachiko Takaishi; Miyuki Nagasaki; Yoshiko Onozawa; Ikue Iino; Hiroaki Maeda; Tomoaki Komai; Tomiichiro Oda
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

Review 10.  G protein-coupled receptors for energy metabolites as new therapeutic targets.

Authors:  Clara C Blad; Cong Tang; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2012-07-13       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.